Company Sector
Stem Cells
Stem Cells includes companies developing therapies or regenerative approaches based on stem cell biology. These businesses are often followed for their potential in tissue repair, rare disease, and chronic degenerative conditions, though clinical translation can be complex and slow.
Why watch Stem Cells
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Stem Cells news
The latest feed items from companies currently grouped under Stem Cells.
- 01
BCLIBrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman
Source: Brainstorm Cell Therapeutics Inc.
- 02
JSPRJasper Therapeutics Announces Merger with Kira Pharmaceuticals
Source: Jasper Therapeutics
- 03
PSTVPlus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
Source: PLUS THERAPEUTICS, Inc.
- 04
BCLIBrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
Source: Brainstorm Cell Therapeutics Inc.
- 05
MESOASX CEO Connect Presentation
Source: Mesoblast
- 06
JSPRJasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
Source: Jasper Therapeutics
- 07
BCLIBrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
Source: Brainstorm Cell Therapeutics Inc.
- 08
- 09
BCLIBrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market
Source: Brainstorm Cell Therapeutics Inc.
- 10
PSTVPlus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
Source: PLUS THERAPEUTICS, Inc.
- 11
- 12
BCLIBrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
Source: Brainstorm Cell Therapeutics Inc.
- 13
JSPRJasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Source: Jasper Therapeutics
- 14
- 15
PSTVPlus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic
Source: PLUS THERAPEUTICS, Inc.
- 16
MESOQuarterly Activities/Appendix 4C Cash Flow Report
Source: Mesoblast
- 17
MESOPatient Recruitment Target Achieved in CLBP Pivotal Trial
Source: Mesoblast
- 18
- 19
- 20
PSTVPlus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Source: PLUS THERAPEUTICS, Inc.
Companies in Stem Cells
6 companies tagged with Stem Cells.
Frequently Asked Questions
What does the Stem Cells sector include?
Stem Cells includes companies developing therapies or regenerative approaches based on stem cell biology. These businesses are often followed for their potential in tissue repair, rare disease, and chronic degenerative conditions, though clinical translation can be complex and slow.
How many companies are currently tagged with Stem Cells?
6 companies are currently grouped under Stem Cells on BioPharmSignal.
Which companies are most visible in the Stem Cells group right now?
BCLI, JSPR, LNTH, MESO are among the companies currently shown on this sector page.
How can I watch news for Stem Cells?
Use the Watch button on this page to subscribe to Stem Cells headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Stem Cells?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Stem Cells.